Bullish & Foolish
Full SER fundamentals All 466 on the Survival Watch

SERSerina Therapeutics, Inc.

Is Serina Therapeutics struggling financially?

Yes, by its own account. Serina Therapeutics told the SEC on 14 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

30/100

Fragile

Sector
Biotech/Pharma
Market cap
$72.9M
Source filing
10-Q 14 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 13months

    If the burn speeds up

    Empty by Jul 2027

  • 18months

    If it eases off

    Empty by Dec 2027

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$23.0M

÷

Cash burned over the last 12 months

$18.0M

What Serina Therapeutics told the SEC

…other funding requirements for the twelve months from the issuance of these unaudited condensed consolidated interim financial statements. As such, there is substantial doubt about the Company’s ability to continue as a going concern. The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including, but not limited to, technical risks associated with the…

Serina Therapeutics, Inc., Form 10-Q, filed 14 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 44.0% share-count increase The company issued stock. Each share now owns 30.6% less of the business than a year ago, before any change in the price.
  • Cash burn is narrowing It is spending 39% less cash per year than it was, so the runway above is lengthening rather than shortening.

Other Biotech/Pharma companies that filed the doubt